当前位置:首页 - 行情中心 - 科伦药业(002422) - 财务分析 - 现金流量表

科伦药业

(002422)

  

流通市值:468.68亿  总市值:573.54亿
流通股本:13.06亿   总股本:15.98亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金10,336,605,8075,020,068,00625,272,264,28318,804,468,884
  收到的税费返还188,459,68186,337,019114,794,30099,932,333
  收到其他与经营活动有关的现金203,590,29477,712,228380,397,499262,311,268
  经营活动现金流入小计10,728,655,7825,184,117,25325,767,456,08219,166,712,485
  购买商品、接受劳务支付的现金5,301,731,4542,567,894,83112,405,028,4419,204,638,631
  支付给职工以及为职工支付的现金2,013,620,1141,240,832,4153,487,925,0292,616,989,544
  支付的各项税费1,136,899,242507,186,3512,883,953,8412,171,051,955
  支付其他与经营活动有关的现金1,086,870,095418,819,4122,497,686,9271,898,607,775
  经营活动现金流出小计9,539,120,9054,734,733,00921,274,594,23815,891,287,905
  经营活动产生的现金流量净额1,189,534,877449,384,2444,492,861,8443,275,424,580
二、投资活动产生的现金流量:
  收回投资收到的现金12,641,939,3123,984,820,00011,062,613,9279,324,058,478
  取得投资收益收到的现金110,526,76927,840,921209,569,216190,930,034
  处置固定资产、无形资产和其他长期资产收回的现金净额10,558,887689,9878,363,8213,883,098
  处置子公司及其他营业单位收到的现金净额11,357,500-36,896,50036,896,500
  收到的其他与投资活动有关的现金28,783,0405,000,000--
  投资活动现金流入小计12,803,165,5084,018,350,90811,317,443,4649,555,768,110
  购建固定资产、无形资产和其他长期资产支付的现金766,900,166412,916,4491,678,259,6151,282,437,437
  投资支付的现金12,554,019,4614,295,505,81911,378,623,1719,662,992,063
  取得子公司及其他营业单位支付的现金10,750,000-2,510,000-
  支付其他与投资活动有关的现金--77,418,669-
  投资活动现金流出小计13,331,669,6274,708,422,26813,136,811,45510,945,429,500
  投资活动产生的现金流量净额-528,504,119-690,071,360-1,819,367,991-1,389,661,390
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,790,370,051-523,336,701523,336,701
  其中:子公司吸收少数股东投资收到的现金1,790,370,051-523,336,701523,336,701
  取得借款收到的现金1,997,040,0001,403,460,0004,914,109,8724,173,527,321
  收到其他与筹资活动有关的现金32,542,49027,130,995183,845,972163,882,491
  筹资活动现金流入小计3,819,952,5411,430,590,9955,621,292,5454,860,746,513
  偿还债务支付的现金1,496,363,732990,238,7326,593,687,0064,378,627,533
  分配股利、利润或偿付利息支付的现金1,088,476,76825,875,3462,014,622,9321,569,023,488
  其中:子公司支付给少数股东的股利、利润240,433,306240,000203,053,883203,053,953
  支付其他与筹资活动有关的现金67,127,92947,280,094317,258,713281,781,587
  筹资活动现金流出小计2,651,968,4291,063,394,1728,925,568,6516,229,432,608
  筹资活动产生的现金流量净额1,167,984,112367,196,823-3,304,276,106-1,368,686,095
四、汇率变动对现金及现金等价物的影响-2,186,9653,846,622-12,779,820-10,344,335
五、现金及现金等价物净增加额1,826,827,905130,356,329-643,562,073506,732,760
  加:期初现金及现金等价物余额3,944,762,0743,944,762,0744,588,324,1474,588,324,147
  期末现金及现金等价物余额5,771,589,9794,075,118,4033,944,762,0745,095,056,907
补充资料:
  净利润1,113,856,403-3,361,954,393-
  资产减值准备95,193,323-239,720,800-
  固定资产和投资性房地产折旧595,283,247-1,103,344,257-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧595,283,247-1,103,344,257-
  无形资产摊销61,700,262-101,616,175-
  长期待摊费用摊销10,871,020-16,702,989-
  处置固定资产、无形资产和其他长期资产的损失-3,303,447--807,537-
  固定资产报废损失--10,953,403-
  公允价值变动损失-15,139,177--19,898,352-
  财务费用53,096,611-134,732,016-
  投资损失-139,968,737--345,018,134-
  递延所得税22,685,040--79,328,441-
  其中:递延所得税资产减少8,134,110--82,898,340-
    递延所得税负债增加14,550,930-3,569,899-
  存货的减少168,158,307--84,663,344-
  经营性应收项目的减少-358,151,820--27,764,076-
  经营性应付项目的增加-532,595,551--173,987,201-
  其他80,163,630-178,554,275-
  现金的期末余额5,771,589,979-3,944,762,074-
  减:现金的期初余额3,944,762,074-4,588,324,147-
  现金及现金等价物的净增加额1,826,827,905--643,562,073-
公告日期2025-08-292025-04-302025-04-242024-10-29
审计意见(境内)标准无保留意见
TOP↑